David MacDonald
Chief Tech/Sci/R&D Officer at XORTX THERAPEUTICS INC.
David MacDonald active positions
| Companies | Position | Start | End |
|---|---|---|---|
| XORTX THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2022-01-19 | - |
Career history of David MacDonald
Former positions of David MacDonald
| Companies | Position | Start | End |
|---|---|---|---|
| Immunoflex Therapeutics, Inc. | Chief Tech/Sci/R&D Officer | 2019-12-31 | 2020-12-31 |
| Biovail Contract Research Division | Corporate Officer/Principal | - | - |
Hemosol Corp. /Old/
 Hemosol Corp. /Old/ Pharmaceuticals: MajorHealth Technology Hemosol Inc. is an integrated biopharmaceutical company focused on the development of a portfolio of products based on human hemoglobin. | Corporate Officer/Principal | - | - |
| Syntex, Inc. | Corporate Officer/Principal | - | - |
MSI Methylation Sciences, Inc.
 MSI Methylation Sciences, Inc. Pharmaceuticals: MajorHealth Technology MSI Methylation Sciences, Inc. engages in drug development through compound leverage. It focuses on developing pharmaceuticals based on molecules with proven efficacy that are under exploited in pharmaceutical markets. The firm offers s-adenosyl methionine, is a prescription drug used as a dietary supplement. The company was founded by Barry J. Guld and Nancy Harrison in 2006 and is headquartered in Burnaby, Canada. | Chief Tech/Sci/R&D Officer | 2007-12-31 | 2017-02-28 |
| President | 2017-02-28 | - | |
Active Pass Pharmaceuticals, Inc.
 Active Pass Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Active Pass Pharmaceuticals, Inc. develops drugs for infectious diseases. It engages in the development of drugs that inhibit ABC transporters. The firm also provides portfolio of therapeutic programs, including age-related macular degeneration, travelers' diarrhea, and lipid disorders. The company was founded by Peter B Reiner in 1998 and is headquartered in Vancouver, Canada. | Chief Executive Officer | 2004-05-31 | - |
| President | 2004-05-31 | - |
Training of David MacDonald
| University of Alberta | Doctorate Degree |
Statistics
International
| Canada | 9 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 3 |
| President | 2 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 2 |
| Miscellaneous | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| XORTX THERAPEUTICS INC. | Health Technology |
| Private companies | 6 |
|---|---|
Active Pass Pharmaceuticals, Inc.
Active Pass Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Active Pass Pharmaceuticals, Inc. develops drugs for infectious diseases. It engages in the development of drugs that inhibit ABC transporters. The firm also provides portfolio of therapeutic programs, including age-related macular degeneration, travelers' diarrhea, and lipid disorders. The company was founded by Peter B Reiner in 1998 and is headquartered in Vancouver, Canada. | Health Technology |
MSI Methylation Sciences, Inc.
MSI Methylation Sciences, Inc. Pharmaceuticals: MajorHealth Technology MSI Methylation Sciences, Inc. engages in drug development through compound leverage. It focuses on developing pharmaceuticals based on molecules with proven efficacy that are under exploited in pharmaceutical markets. The firm offers s-adenosyl methionine, is a prescription drug used as a dietary supplement. The company was founded by Barry J. Guld and Nancy Harrison in 2006 and is headquartered in Burnaby, Canada. | Health Technology |
| Syntex, Inc. | Miscellaneous |
Hemosol Corp. /Old/
Hemosol Corp. /Old/ Pharmaceuticals: MajorHealth Technology Hemosol Inc. is an integrated biopharmaceutical company focused on the development of a portfolio of products based on human hemoglobin. | Health Technology |
| Biovail Contract Research Division | Commercial Services |
| Immunoflex Therapeutics, Inc. |
- Stock Market
- Insiders
- David MacDonald
- Experience
